A randomized clinical study using optical coherence tomography to evaluate the short-term effects of high-intensity

Muzammil Rafique1,2, Ole Geir Solberg1, Lars Gullestad1,2,3

  • 1Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.

Clinical Transplantation
|November 8, 2021
PubMed

Insights

High-intensity interval training (HIT) did not significantly slow cardiac allograft vasculopathy (CAV) progression in new heart transplant recipients compared to moderate-intensity training over nine months. Early intervention with HIT did not attenuate CAV development in this patient group.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Exercise Physiology

Background:

  • Cardiac allograft vasculopathy (CAV) is a primary cause of death in long-term heart transplant survivors.
  • Current preventive and treatment strategies for CAV are limited.
  • Understanding exercise interventions' effects on CAV is crucial for improving patient outcomes.

Purpose of the Study:

  • To assess the short-term impact of high-intensity interval training (HIT) on CAV progression in de novo heart transplant (HTx) recipients.
  • To compare the effects of HIT versus moderate-intensity continuous training (MICT) on intima area changes in HTx recipients.
  • To evaluate CAV development using optical coherence tomography (OCT) over a nine-month period.

Main Methods:

  • A subgroup of 81 patients from the HITTS study were randomized to HIT or MICT for nine months.
  • Optical coherence tomography (OCT) was used to compare baseline and 12-month images for CAV assessment.
  • The primary endpoint was the change in mean intima area, analyzed in 56 patients with paired OCT data.

Main Results:

  • The mean intima area increased by 25% across the entire study population.
  • Intima area progression was twofold higher in the MICT group compared to the HIT group.
  • The difference in CAV progression between HIT and MICT was not statistically significant (P = 0.29).

Conclusions:

  • Early initiation of HIT does not appear to attenuate CAV progression compared to MICT in de novo HTx recipients.
  • Further research is needed to explore optimal exercise strategies for managing CAV.
  • HIT may not be a superior intervention for preventing early CAV development post-heart transplantation.